Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-galactosidase activity	GLA NAGA	1.83e-05	2	86	2	GO:0004557
GeneOntologyMolecularFunction	oxidoreductase activity	NLRP11 KDM4D NDUFAF5 KDM4C RRM2B TECR CYP26C1 AKR7A3 LIPF CAT IDH2 PLOD2 AKR7A2	2.31e-05	766	86	13	GO:0016491
GeneOntologyMolecularFunction	phenanthrene-9,10-epoxide hydrolase activity	AKR7A3 AKR7A2	5.48e-05	3	86	2	GO:0019119
GeneOntologyMolecularFunction	phenanthrene-epoxide hydrolase activity	AKR7A3 AKR7A2	5.48e-05	3	86	2	GO:0019118
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	ATP8B3 ABCA1 ABCA3 ANO1	6.87e-05	51	86	4	GO:0140303
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ATP8B3 ABCA1 ABCA3	2.34e-04	28	86	3	GO:0140326
GeneOntologyMolecularFunction	histone H3K9me2/H3K9me3 demethylase activity	KDM4D KDM4C	2.72e-04	6	86	2	GO:0140684
GeneOntologyMolecularFunction	phospholipid transporter activity	ATP8B3 ABCA1 ABCA3 ANO1	2.93e-04	74	86	4	GO:0005548
GeneOntologyMolecularFunction	galactosidase activity	GLA NAGA	3.80e-04	7	86	2	GO:0015925
GeneOntologyMolecularFunction	phosphatidylserine floppase activity	ATP8B3 ABCA1	6.47e-04	9	86	2	GO:0090556
GeneOntologyMolecularFunction	glycine transmembrane transporter activity	SLC7A8 SLC6A9	8.07e-04	10	86	2	GO:0015187
GeneOntologyMolecularFunction	epoxide hydrolase activity	AKR7A3 AKR7A2	9.83e-04	11	86	2	GO:0004301
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC7A8 SLC6A9 ABCA1 ABCA3 SLC12A2 IPO8 SLC35E3 SLC15A3	1.04e-03	477	86	8	GO:0022804
GeneOntologyMolecularFunction	hydrolase activity, acting on ether bonds	AKR7A3 AKR7A2	1.39e-03	13	86	2	GO:0016801
GeneOntologyMolecularFunction	ether hydrolase activity	AKR7A3 AKR7A2	1.39e-03	13	86	2	GO:0016803
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	NLRP11 KDM4D KDM4C CYP26C1 PLOD2	1.52e-03	194	86	5	GO:0016705
GeneOntologyMolecularFunction	aldose reductase (NADPH) activity	AKR7A3 AKR7A2	1.61e-03	14	86	2	GO:0004032
GeneOntologyMolecularFunction	histone H3K9 demethylase activity	KDM4D KDM4C	1.61e-03	14	86	2	GO:0032454
GeneOntologyMolecularFunction	floppase activity	ATP8B3 ABCA1	2.12e-03	16	86	2	GO:0140328
Domain	Glyco_hydro_27/36_CS	GLA NAGA	2.00e-05	2	84	2	IPR000111
Domain	ALPHA_GALACTOSIDASE	GLA NAGA	2.00e-05	2	84	2	PS00512
Domain	Melibiase_2	GLA NAGA	2.00e-05	2	84	2	PF16499
Domain	Glyco_hydro_27	GLA NAGA	2.00e-05	2	84	2	IPR002241
Domain	Cse1	IPO8 IPO7	5.98e-05	3	84	2	IPR013713
Domain	Cse1	IPO8 IPO7	5.98e-05	3	84	2	PF08506
Domain	JmjN	KDM4D KDM4C	8.79e-04	10	84	2	SM00545
Domain	JMJN	KDM4D KDM4C	8.79e-04	10	84	2	PS51183
Domain	JmjN	KDM4D KDM4C	8.79e-04	10	84	2	PF02375
Domain	JmjN	KDM4D KDM4C	8.79e-04	10	84	2	IPR003349
Domain	ABC_A	ABCA1 ABCA3	1.28e-03	12	84	2	IPR026082
Domain	-	GLA NAGA	1.76e-03	14	84	2	2.60.40.1180
Domain	IMPORTIN_B_NT	IPO8 IPO7	1.76e-03	14	84	2	PS50166
Domain	Glyco_hydro_b	GLA NAGA	2.02e-03	15	84	2	IPR013780
Domain	IBN_N	IPO8 IPO7	2.02e-03	15	84	2	PF03810
Domain	Laminin_N	LAMA1 NTN1	2.30e-03	16	84	2	IPR008211
Domain	IBN_N	IPO8 IPO7	2.30e-03	16	84	2	SM00913
Domain	LAMININ_NTER	LAMA1 NTN1	2.30e-03	16	84	2	PS51117
Domain	Laminin_N	LAMA1 NTN1	2.30e-03	16	84	2	PF00055
Domain	-	AKR7A3 AKR7A2	2.30e-03	16	84	2	3.20.20.100
Domain	LamNT	LAMA1 NTN1	2.30e-03	16	84	2	SM00136
Domain	NADP_OxRdtase_dom	AKR7A3 AKR7A2	2.60e-03	17	84	2	IPR023210
Domain	C345C	C3 NTN1	2.60e-03	17	84	2	SM00643
Domain	Aldo_ket_red	AKR7A3 AKR7A2	2.60e-03	17	84	2	PF00248
Domain	Aldo/ket_red/Kv-b	AKR7A3 AKR7A2	2.60e-03	17	84	2	IPR001395
Domain	Importin-beta_N	IPO8 IPO7	2.60e-03	17	84	2	IPR001494
Domain	NTR	C3 NTN1	3.25e-03	19	84	2	PF01759
Domain	Netrin_module_non-TIMP	C3 NTN1	3.25e-03	19	84	2	IPR018933
Domain	ARM-type_fold	DOCK2 IPO8 PSME4 IPO7 PIK3CB AGBL1	4.24e-03	339	84	6	IPR016024
Domain	AA-permease/SLC12A_dom	SLC7A8 SLC12A2	4.36e-03	22	84	2	IPR004841
Domain	EPHD	JADE3 KDM4C	4.36e-03	22	84	2	PS51805
Domain	AA_permease	SLC7A8 SLC12A2	4.36e-03	22	84	2	PF00324
Domain	NTR	C3 NTN1	4.76e-03	23	84	2	PS50189
Domain	Netrin_domain	C3 NTN1	4.76e-03	23	84	2	IPR001134
Domain	JmjC	KDM4D KDM4C	5.17e-03	24	84	2	PF02373
Domain	-	GYG2 EXT2 PLOD2	5.82e-03	81	84	3	3.90.550.10
Domain	TIMP-like_OB-fold	C3 NTN1	6.06e-03	26	84	2	IPR008993
Domain	TPR_REGION	NAA25 TTC17 TTC39A TTC22	6.55e-03	165	84	4	PS50293
Domain	TPR	NAA25 TTC17 TTC39A TTC22	6.55e-03	165	84	4	PS50005
Domain	SH3_2	DOCK2 MYO7B ZDHHC6	6.87e-03	86	84	3	IPR011511
Domain	SH3_2	DOCK2 MYO7B ZDHHC6	6.87e-03	86	84	3	PF07653
Domain	Nucleotide-diphossugar_trans	GYG2 EXT2 PLOD2	7.32e-03	88	84	3	IPR029044
Domain	ARM-like	DOCK2 IPO8 PSME4 IPO7 AGBL1	7.43e-03	270	84	5	IPR011989
Pubmed	C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast.	LAMA1 C3	6.48e-06	2	89	2	3488995
Pubmed	A novel conserved targeting motif found in ABCA transporters mediates trafficking to early post-Golgi compartments.	ABCA1 ABCA3	6.48e-06	2	89	2	21586796
Pubmed	Alpha-galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutation.	GLA F5	6.48e-06	2	89	2	16514103
Pubmed	Increased Expression of the ABCA1 and ABCA3 Transporter Genes is Associated with Cisplatin Resistance in Breast Cancer Cells.	ABCA1 ABCA3	6.48e-06	2	89	2	38019257
Pubmed	Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases.	GLA NAGA	6.48e-06	2	89	2	20444686
Pubmed	Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue.	ABCA1 ABCA3	6.48e-06	2	89	2	19902402
Pubmed	Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease.	GLA NAGA	6.48e-06	2	89	2	19853240
Pubmed	[Synergistic effect of deficiency in thrombosis-related genes].	GLA F5	6.48e-06	2	89	2	20533258
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	GLA SLC12A2 SPCS1 ZDHHC6 ATP6AP2 NAGA LAMA1 ELOVL5 TTC17 EXT2 PLOD2 CPVL DNASE2	1.15e-05	1201	89	13	35696571
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	NAA25 SLC12A2 IPO8 IPO7 SPCS1 ATP6AP2 TECR CAT EXT2 QARS1 APOBEC3B FOXG1 TOP2B	1.17e-05	1203	89	13	29180619
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	TRHDE GLA ATP6AP2 NAGA AKR7A3 TMPRSS2 C3 CAT IDH2 CPVL DNASE2 AKR7A2	1.82e-05	1070	89	12	23533145
Pubmed	[Purification of recombinant AKR7A5 protein and measurement of substrate specificity of AKR7A5 towards naphthoquinone and its derivatives].	AKR7A3 AKR7A2	1.94e-05	3	89	2	22863590
Pubmed	Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.	AKR7A3 AKR7A2	1.94e-05	3	89	2	12123834
Pubmed	Aldo-keto reductase 7A5 (AKR7A5) attenuates oxidative stress and reactive aldehyde toxicity in V79-4 cells.	AKR7A3 AKR7A2	1.94e-05	3	89	2	24590062
Pubmed	Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.	AKR7A3 AKR7A2	1.94e-05	3	89	2	12071861
Pubmed	Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis.	AKR7A3 AKR7A2	1.94e-05	3	89	2	16919859
Pubmed	DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.	ABCA1 TOP2B	1.94e-05	3	89	2	23466610
Pubmed	Preferential utilization of Imp7/8 in nuclear import of Smads.	IPO8 IPO7	1.94e-05	3	89	2	18519565
Pubmed	AKR7A5 knockout promote acute liver injury by inducing inflammatory response, oxidative stress and apoptosis in mice.	AKR7A3 AKR7A2	1.94e-05	3	89	2	39365156
Pubmed	Diversity within the JMJD2 histone demethylase family.	KDM4D KDM4C	1.94e-05	3	89	2	17207460
Pubmed	Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV.	SLC12A2 FOXG1	1.94e-05	3	89	2	18833191
Pubmed	Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation.	ABCA1 ABCA3	1.94e-05	3	89	2	28241820
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	GLA IPO7 SPCS1 ATP6AP2 TECR C3 CAT TTC17 EXT2 QARS1 PLOD2 DNASE2 AKR7A2	2.57e-05	1297	89	13	33545068
Pubmed	Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1 in a region frequently altered in human tumour cells.	AKR7A3 AKR7A2	3.87e-05	4	89	2	12879023
Pubmed	Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes.	LAMA1 PLOD2	3.87e-05	4	89	2	16467571
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	IPO8 IPO7 TECR CAPN2 SNX27 C3 CAT IDH2 QARS1	4.27e-05	647	89	9	26618866
Pubmed	Cystathionine γ-lyase(CSE)/hydrogen sulfide system is regulated by miR-216a and influences cholesterol efflux in macrophages via the PI3K/AKT/ABCA1 pathway.	ABCA1 PIK3CB	6.44e-05	5	89	2	26772887
Pubmed	ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol.	ABCA1 ABCA3	6.44e-05	5	89	2	17142808
Pubmed	Early uneven ear input induces long-lasting differences in left-right motor function.	SLC12A2 FOXG1	6.44e-05	5	89	2	29534062
Pubmed	Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family.	KDM4D KDM4C	6.44e-05	5	89	2	21914792
Pubmed	Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells.	KDM4D KDM4C	6.44e-05	5	89	2	16738407
Pubmed	A novel class of RanGTP binding proteins.	IPO8 IPO7	6.44e-05	5	89	2	9214382
Pubmed	A causative link between inner ear defects and long-term striatal dysfunction.	SLC12A2 FOXG1	6.44e-05	5	89	2	24009395
Pubmed	Identification and characterization of JMJD2 family genes in silico.	KDM4D KDM4C	9.65e-05	6	89	2	15138608
Pubmed	Conditional and constitutive expression of a Tbx1-GFP fusion protein in mice.	NTN1 FOXG1	9.65e-05	6	89	2	23971992
Pubmed	Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta.	FOXG1 TOP2B	9.65e-05	6	89	2	12773624
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	SLC12A2 ATP6AP2 CAPN2 ANO1 TMPRSS2 EXT2 PLOD2	1.00e-04	417	89	7	19199708
Pubmed	Signal recognition particle protein 19 is imported into the nucleus by importin 8 (RanBP8) and transportin.	IPO8 IPO7	1.35e-04	7	89	2	11682607
Pubmed	Rb/E2F regulates expression of neogenin during neuronal migration.	NTN1 FOXG1	1.35e-04	7	89	2	21059867
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	NAA25 GLA SLC12A2 IPO7 ATP6AP2 TECR CAPN2 EXT2 QARS1 PLOD2	1.49e-04	942	89	10	31073040
Pubmed	Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.	ABCA1 ABCA3	1.79e-04	8	89	2	24293640
Pubmed	Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E.	IPO8 IPO7	1.79e-04	8	89	2	27114554
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	IPO8 IPO7 ATP6AP2 TECR CAPN2 SNX27 C3 TTC17 EXT2 CPVL	1.95e-04	974	89	10	28675297
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	NAGA SNX27 C3 CAT IDH2 F5 TOP2B	2.23e-04	475	89	7	31040226
Pubmed	Hmx2 homeobox gene control of murine vestibular morphogenesis.	NTN1 FOXG1	2.30e-04	9	89	2	11748138
Pubmed	Genetic interactions support an inhibitory relationship between bone morphogenetic protein 2 and netrin 1 during semicircular canal formation.	NTN1 FOXG1	2.30e-04	9	89	2	30770380
Pubmed	Locations of human and mouse genes encoding the RFX1 and RFX2 transcription factor proteins.	LAMA1 C3	2.30e-04	9	89	2	8661125
Pubmed	Store-operated Ca2+ entry regulates Ca2+-activated chloride channels and eccrine sweat gland function.	SLC12A2 ANO1	2.88e-04	10	89	2	27721237
Pubmed	ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis.	TECR ELOVL5	2.88e-04	10	89	2	20937905
Pubmed	Gata2 is required for the development of inner ear semicircular ducts and the surrounding perilymphatic space.	NTN1 FOXG1	2.88e-04	10	89	2	20652952
Pubmed	The homeodomain protein vax1 is required for axon guidance and major tract formation in the developing forebrain.	NTN1 FOXG1	2.88e-04	10	89	2	10601035
Pubmed	Calcium signaling induces partial EMT and renal fibrosis in a Wnt4mCherry knock-in mouse model.	COL10A1 PIEZO2 SLC12A2	3.46e-04	53	89	3	38653356
Pubmed	Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins.	KDM4D KDM4C	3.51e-04	11	89	2	19144645
Pubmed	Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation.	IPO7 TECR	3.51e-04	11	89	2	35842443
Pubmed	Genome-wide atlas of gene expression in the adult mouse brain.	CLIC4 NTN1 FOXG1	3.66e-04	54	89	3	17151600
Pubmed	Specific pupylation as IDEntity reporter (SPIDER) for the identification of protein-biomolecule interactions.	CAPN2 C3 F5	4.07e-04	56	89	3	37059927
Pubmed	The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping.	AKR7A3 AKR7A2	4.20e-04	12	89	2	10495887
Pubmed	Mice deficient in Ext2 lack heparan sulfate and develop exostoses.	COL10A1 EXT2	4.96e-04	13	89	2	16236767
Pubmed	A targeted mouse Otx2 mutation leads to severe defects in gastrulation and formation of axial mesoderm and to deletion of rostral brain.	NTN1 FOXG1	4.96e-04	13	89	2	8565836
Pubmed	Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.	TRIM22 TOP2B	5.78e-04	14	89	2	19902255
Pubmed	Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.	COL10A1 C3	5.78e-04	14	89	2	21665990
Pubmed	Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.	KDM4D KDM4C	5.78e-04	14	89	2	16603238
Pubmed	Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.	LIMK2 PIK3CB	5.78e-04	14	89	2	20041213
Pubmed	Floor-plate-derived netrin-1 is dispensable for commissural axon guidance.	NTN1 FOXG1	5.78e-04	14	89	2	28445456
Pubmed	Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.	CAT F5	5.78e-04	14	89	2	20078877
Pubmed	Identification of genes expressed in the mouse limb using a novel ZPA microarray approach.	ANO1 NTN1	6.65e-04	15	89	2	17911046
Pubmed	A Brain-Region-Specific Neural Pathway Regulating Germinal Matrix Angiogenesis.	LAMA1 FOXG1	6.65e-04	15	89	2	28535372
Pubmed	Multiple roles for Pax2 in the embryonic mouse eye.	NTN1 FOXG1	6.65e-04	15	89	2	33428890
Pubmed	Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).	ABCA1 C3	6.65e-04	15	89	2	20385826
Pubmed	Goosecoid and HNF-3beta genetically interact to regulate neural tube patterning during mouse embryogenesis.	NTN1 FOXG1	6.65e-04	15	89	2	9226455
Pubmed	Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt.	IPO7 SPCS1 ATP6AP2 ATP5MJ TOP2B	6.74e-04	271	89	5	25737280
Pubmed	Identification of cAMP analogue inducible genes in RAW264 macrophages.	ABCA1 SLC15A3	7.59e-04	16	89	2	11004510
Pubmed	Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects.	NTN1 FOXG1	7.59e-04	16	89	2	8543157
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	TRHDE GLA TECR PLOD2	8.52e-04	164	89	4	32409323
Pubmed	Dual origins of the mammalian accessory olfactory bulb revealed by an evolutionarily conserved migratory stream.	NTN1 FOXG1	8.59e-04	17	89	2	23292680
Pubmed	Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.	ABCA1 C3	8.59e-04	17	89	2	20385819
Pubmed	Effects of gestational hypothyroidism on mouse brain development: Gabaergic systems and oxidative stress.	SLC12A2 CAT	8.59e-04	17	89	2	39048051
Pubmed	PTEN Regulates Glucose Transporter Recycling by Impairing SNX27 Retromer Assembly.	SNX27 CAT	8.59e-04	17	89	2	29117568
Pubmed	Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope.	PIEZO2 APOBEC3B	9.65e-04	18	89	2	37914931
Pubmed	Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.	C3 CAT EXT2	9.95e-04	76	89	3	19336475
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	GLA IPO7 NAGA TTC17 PLOD2 CPVL DNASE2	1.01e-03	613	89	7	22268729
Pubmed	Meis2 Is Required for Inner Ear Formation and Proper Morphogenesis of the Cochlea.	MYO7B FOXG1	1.08e-03	19	89	2	34124068
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	GLA IPO7 ZNF75D CAT QARS1 PLOD2	1.08e-03	451	89	6	36168627
Pubmed	The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase.	IPO8 ELOVL5 C3 CAT IDH2 PLOD2	1.10e-03	453	89	6	27113764
Pubmed	CYP26A1 and CYP26C1 cooperatively regulate anterior-posterior patterning of the developing brain and the production of migratory cranial neural crest cells in the mouse.	CYP26C1 FOXG1	1.19e-03	20	89	2	17067568
Pubmed	Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human.	AKR7A3 AKR7A2	1.19e-03	20	89	2	9828140
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	IPO8 IPO7 PIK3CB TECR	1.28e-03	183	89	4	23956138
Pubmed	Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.	KDM4D KDM4C	1.32e-03	21	89	2	27626377
Pubmed	Hmx2 and Hmx3 homeobox genes direct development of the murine inner ear and hypothalamus and can be functionally replaced by Drosophila Hmx.	NTN1 FOXG1	1.32e-03	21	89	2	15363417
Pubmed	Dynamic FoxG1 expression coordinates the integration of multipolar pyramidal neuron precursors into the cortical plate.	NTN1 FOXG1	1.45e-03	22	89	2	22726835
Pubmed	Differences in health status affect susceptibility and mapping of genetic loci for atherosclerosis (fatty streak) in inbred mice.	SLC12A2 CPVL	1.45e-03	22	89	2	22837474
Pubmed	Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus.	ABCA3 IPO8	1.58e-03	23	89	2	10708515
Pubmed	Perioperative genomic profiles using structure-specific oligonucleotide probes.	ABCA1 F5	1.58e-03	23	89	2	19474452
Pubmed	Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin.	COL10A1 PIEZO2	1.72e-03	24	89	2	32186512
Pubmed	An interaction between OTULIN and SCRIB uncovers roles for linear ubiquitination in planar cell polarity.	SNX27 CPVL	1.87e-03	25	89	2	37589075
Pubmed	Peroxisome Metabolism Contributes to PIEZO2-Mediated Mechanical Allodynia.	PIEZO2 LAMA1	1.87e-03	25	89	2	35681537
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	GLA IPO7 SNX27 C3 CAT	1.94e-03	344	89	5	30333137
Pubmed	Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994.	CAT F5	2.02e-03	26	89	2	21054877
Pubmed	A Dynamic Unfolded Protein Response Contributes to the Control of Cortical Neurogenesis.	SLC6A9 FOXG1	2.02e-03	26	89	2	26651292
Pubmed	Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways.	COL10A1 PIK3CB	2.02e-03	26	89	2	21367821
Interaction	TMEM106B interactions	GLA SPCS1 ATP6AP2 TECR TMPRSS2 C3 TTC17 EXT2 PLOD2	5.07e-06	309	83	9	int:TMEM106B
GeneFamily	ATP binding cassette subfamily A	ABCA1 ABCA3	1.06e-03	14	63	2	805
GeneFamily	Aldo-keto reductases	AKR7A3 AKR7A2	1.22e-03	15	63	2	399
GeneFamily	Armadillo repeat containing\|Importins	IPO8 IPO7	1.76e-03	18	63	2	596
GeneFamily	Solute carriers	SLC7A8 SLC6A9 SLC12A2 SLC35E3 SLC15A3 SLC44A3	2.49e-03	395	63	6	752
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM4D KDM4C	3.14e-03	24	63	2	485
Coexpression	GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN	ABCA1 GLA NAGA SNX27 CAT TTC17 SLC15A3	5.10e-06	200	88	7	M4600
Coexpression	ESC_V6.5_UP_EARLY.V1_DN	KLK10 MYO7B CAPN2 LAMA1 NTN1 SULT1E1	1.88e-05	163	88	6	M2769
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOCK2 GLA CAT SLC15A3 CPVL DNASE2	1.46e-06	178	88	6	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	Control-Epithelial_alveolar-AT_2-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 C3 CAT TTC39A SLC44A3	1.66e-06	182	88	6	e97681a4102f3095d5d9e90ad70f1dc46e90983a
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 C3 CAT TTC39A SLC44A3	1.77e-06	184	88	6	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	droplet-Fat-SCAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 IPO7 ANO1 TMPRSS2 CADPS2 SLC44A3	1.94e-06	187	88	6	5fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCell	droplet-Fat-SCAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 IPO7 ANO1 TMPRSS2 CADPS2 SLC44A3	1.94e-06	187	88	6	766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCell	droplet-Fat-SCAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 IPO7 ANO1 TMPRSS2 CADPS2 SLC44A3	1.94e-06	187	88	6	f49d06600060deeb2fc1b1da5b93496535f20104
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	ABCA3 TMPRSS2 C3 TTC39A CADPS2 AGBL1	2.07e-06	189	88	6	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	PND14-Epithelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 SLC12A2 OSBPL6 TMPRSS2 C3 CAT	2.13e-06	190	88	6	f1eeef8f201bf7b96c020c8ab53dd7e05b3060ea
ToppCell	droplet-Fat-Scat-18m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 SLC12A2 ANO1 TMPRSS2 TTC22 SLC44A3	2.26e-06	192	88	6	4098b5170c9995718758a082d1b8bcb86d5a289e
ToppCell	droplet-Fat-Scat-18m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 SLC12A2 ANO1 TMPRSS2 TTC22 SLC44A3	2.26e-06	192	88	6	936028fe851e8dd2b906df0210acc574c017b499
ToppCell	droplet-Fat-Scat-18m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 SLC12A2 ANO1 TMPRSS2 TTC22 SLC44A3	2.26e-06	192	88	6	62e55ed0d46b2e7b07dc42399972a099576cbc5f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ABCA3 TMPRSS2 C3 TTC39A CADPS2 AGBL1	2.33e-06	193	88	6	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 C3 CAT TTC39A ODC1 CADPS2	2.63e-06	197	88	6	ad6f047d003c08413264f39a30ba0f7639a257cd
ToppCell	Control_saline-Epithelial_alveolar-AT_2-AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT TTC39A SLC44A3	2.63e-06	197	88	6	f870a26f322668781e3d2832c5d9ef2c7c91011f
ToppCell	control-HLA-DR-_S100A+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NAGA SNX27 CAT SLC15A3 CPVL F5	2.86e-06	200	88	6	9e3e13a68bc1110fa000ec2d80f4c654ddbce17e
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CARF BUB1 SLC35E3 F5 SLC44A3	2.09e-05	168	88	5	1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CARF BUB1 SLC35E3 F5 SLC44A3	2.09e-05	168	88	5	69f534de0f9a293047bea03cb1b78551087a8df5
ToppCell	Epithelial-Epithelial-C_(AT2)\|Epithelial / shred on cell class and cell subclass (v4)	ABCA3 SLC12A2 C3 CAT PRRG3	2.40e-05	173	88	5	f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990
ToppCell	facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC7A8 MYO7B SLC35E3 ODC1 AKR7A2	2.68e-05	177	88	5	9c7c6824b9011363851f084a500d665f025b026e
ToppCell	facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC7A8 MYO7B SLC35E3 ODC1 AKR7A2	2.68e-05	177	88	5	2bf639e9e801e5144462ffc957f5739e0dfcd500
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 ANO1 TMPRSS2 CPVL SLC44A3	2.83e-05	179	88	5	88dbec952507d84b85b08165eec80df99ed1e736
ToppCell	facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 ANO1 TMPRSS2 CPVL SLC44A3	2.83e-05	179	88	5	daf8189a22786171e2b629261cf720736aa4ebdb
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KLK10 HS3ST5 GYG2 NTN1 CADPS2	2.90e-05	180	88	5	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AKR7A3 TMPRSS2 HS3ST5 C3 PLOD2	3.06e-05	182	88	5	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 SLC12A2 TMPRSS2 TTC39A PWWP3B	3.14e-05	183	88	5	7eaa6ef7c6cf848fd6489f97677f4406318da22f
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 C3 TTC39A CADPS2	3.14e-05	183	88	5	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 HS3ST5 C3 CADPS2	3.22e-05	184	88	5	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 TMPRSS2 C3 CADPS2 AGBL1	3.22e-05	184	88	5	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 C3 CAT TTC39A ODC1	3.22e-05	184	88	5	157a3d00165bb4a8c52c3e63ae57d9cf57500be7
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GLA C3 CPVL APOBEC3B DNASE2	3.22e-05	184	88	5	97ae5ffecf90df42cc8eea2a247ca589f35a4783
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 C3 CADPS2 SLC44A3	3.31e-05	185	88	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CARF BUB1 LIPF CLIC4 TTC39A	3.31e-05	185	88	5	b4af9ae4c358b48357cb135b740266e1652d886a
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 C3 TTC39A CADPS2	3.40e-05	186	88	5	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TMPRSS2 NTN1 CADPS2 AGBL1 SLC44A3	3.40e-05	186	88	5	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLC7A8 C3 SLC15A3 CPVL DNASE2	3.40e-05	186	88	5	c7e2134454ab5d0885050dd1bb3c3bd15bf497ac
ToppCell	P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	OSBPL6 ANO1 TMPRSS2 PLOD2 SLC44A3	3.40e-05	186	88	5	521e6e007bbae73e7328153aa170cf04ca3c1093
ToppCell	P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	OSBPL6 ANO1 TMPRSS2 PLOD2 SLC44A3	3.48e-05	187	88	5	a4b41904ba05eb76212c949fc3ac197f906c8351
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 C3 CAT TTC39A	3.57e-05	188	88	5	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	15-Distal-Epithelial-Secretory_progenitor\|Distal / Age, Tissue, Lineage and Cell class	KLK10 TMPRSS2 NTN1 PWWP3B SLC44A3	3.57e-05	188	88	5	9a64fb07de611de38d6f24673feb3b81a5e85384
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	SLC6A9 ABCA3 C3 CADPS2 AGBL1	3.57e-05	188	88	5	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE PIK3CB CLIC4 CPVL DNAH7	3.66e-05	189	88	5	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 TMPRSS2 C3 CAT SLC44A3	3.66e-05	189	88	5	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 SLC12A2 C3 CAT PRRG3	3.76e-05	190	88	5	8ff8c586237cf15f930416710bcff45205fe6f70
ToppCell	facs-Large_Intestine-Distal\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6AP2 ANO1 TMPRSS2 CLIC4 TTC39A	3.76e-05	190	88	5	3964a8390522b61b73235151bb0a2ff36b856867
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KLK10 HS3ST5 NTN1 PWWP3B CADPS2	3.85e-05	191	88	5	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	PND14-Epithelial-Epithelial_Alveolar\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 SLC12A2 C3 CAT PRRG3	3.85e-05	191	88	5	5f8b3b2d38b37027901db9a1cccdbd1ff70f29de
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 SLC12A2 C3 CAT PRRG3	3.85e-05	191	88	5	2f71f1fb6b5872d84860840b22e789a87ab14eec
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 SLC12A2 C3 CAT PRRG3	3.85e-05	191	88	5	4ab3056f9af2a6caed39f32288562f480811cd7b
ToppCell	PND03-Epithelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 OSBPL6 ANO1 TMPRSS2 SLC44A3	3.95e-05	192	88	5	d8c23693f690d4d568585537bbfedda05d505b3d
ToppCell	Epithelial\|World / shred on cell class and cell subclass (v4)	ABCA3 OSBPL6 ANO1 TMPRSS2 SLC44A3	3.95e-05	192	88	5	13a3553d9a7c78535679d23d454c63fd08f7d218
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	KLK10 HS3ST5 NTN1 PWWP3B CADPS2	4.05e-05	193	88	5	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	DOCK2 SLC7A8 ABCA1 CPVL MS4A4E	4.15e-05	194	88	5	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIEZO2 SLC12A2 ANO1 TMPRSS2 TTC39A	4.15e-05	194	88	5	715e02e5f3250b1bfdc26b7dfd656ba4e705ea84
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC7A8 ABCA1 NAGA SLC15A3 CPVL	4.25e-05	195	88	5	c16479a10f5ca2e89aea1742dbc5cc4dc9f3ea88
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PIEZO2 CAPN2 NTN1 PRRG3 F5	4.36e-05	196	88	5	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	11.5-Distal-Epithelial-Secretory_progenitor\|Distal / Age, Tissue, Lineage and Cell class	KLK10 TMPRSS2 NTN1 PWWP3B SLC44A3	4.36e-05	196	88	5	2648d64b0e7b59ae78182d55f32699ceea37ff8d
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CADPS2 SLC44A3	4.46e-05	197	88	5	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK2 SLC7A8 ABCA1 CPVL MS4A4E	4.46e-05	197	88	5	10190b877bf46ba2163d203df9dd3b498c66e52f
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CADPS2 SLC44A3	4.46e-05	197	88	5	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC7A8 ABCA1 SLC15A3 CPVL MS4A4E	4.46e-05	197	88	5	e3349a381723393cd255f202afedd0c99037939b
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SLC7A8 ABCA1 ATP6AP2 SLC15A3 DNASE2	4.46e-05	197	88	5	72775eb6c24cfb956436642ac9cd6e4d5c01ea5f
ToppCell	Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	GLA NAGA SLC15A3 CPVL DNASE2	4.46e-05	197	88	5	598fb7a9a8400af49d90807b3155d3cc1c34f505
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC7A8 ABCA1 SLC15A3 CPVL MS4A4E	4.46e-05	197	88	5	e567886d69c6ea8dec87019c2ebc593793cb3107
ToppCell	Control_saline-Epithelial_alveolar-AT_2\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT SLC44A3	4.46e-05	197	88	5	b8f62fcd6eb8f47b3cc41f616126f82c68a36e87
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 C3 CAT TTC39A CADPS2	4.46e-05	197	88	5	1638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCell	10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SLC7A8 ABCA1 ATP6AP2 SLC15A3 DNASE2	4.46e-05	197	88	5	075044c17f1c52008cd3c292c15cbf485b50411e
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.57e-05	198	88	5	d087e738d69ca9853553fde46d4e7a8906439d32
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC7A8 ABCA1 CLIC4 SLC15A3 CPVL	4.57e-05	198	88	5	579a22199643440b98e381147779ced630d4ed66
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KLK10 HS3ST5 NTN1 PWWP3B CADPS2	4.57e-05	198	88	5	5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT ODC1	4.57e-05	198	88	5	6b6572deeca98ccb015f2aa3c5ce27de44445f74
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ABCA1 SLC15A3 CPVL MS4A4E	4.57e-05	198	88	5	6a4161680b46b2c12353a693c403b5a4bb3da03f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA3 SPCS1 C3 CAT ODC1	4.57e-05	198	88	5	d12f37527399038a8f030b45b176bda5c7c8a7ad
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT SLC44A3	4.57e-05	198	88	5	8d9858dcb21f20d0c040b22a2cae543eaebd54bc
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA3 C3 CAT ODC1 CADPS2	4.57e-05	198	88	5	c4e7512f0e1d115f2be8acae6048eda8b6b640b2
ToppCell	LPS_anti-TNF-Epithelial_alveolar\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.57e-05	198	88	5	53e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABCA3 C3 CAT TTC39A ODC1	4.57e-05	198	88	5	d499dced27b0c0e21acfda2c20fa5c114f605085
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid-Microglia\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	DOCK2 SLC7A8 C3 SLC15A3 CPVL	4.57e-05	198	88	5	c0d33629438504a1545e07f0e5af2e76f50fd55b
ToppCell	Control_saline-Epithelial_alveolar-AT_1-2_Progenitor\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCA3 AKR7A3 TMPRSS2 C3 CAT	4.57e-05	198	88	5	cd8a26de6c1cb9c42635146bb7220dd1b41ee97d
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.57e-05	198	88	5	655df75b9692d815c7f6910275e1f684ac63bf62
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.57e-05	198	88	5	82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	DOCK2 SLC7A8 C3 SLC15A3 CPVL	4.57e-05	198	88	5	2b93995f66c7352acc25d6c71d025b847881dacd
ToppCell	10x3'2.3-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SLC7A8 ABCA1 ATP6AP2 SLC15A3 DNASE2	4.57e-05	198	88	5	9a89083280d4253f282300cdf1e61746d1f32407
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.68e-05	199	88	5	3a0af1a13b1760f4213d87d0958dbe3bf3b9a42b
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK2 SLC7A8 ABCA1 CPVL MS4A4E	4.68e-05	199	88	5	f34c15df58fbdc6c90e30800e26fabbf828ad10b
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KLK10 TMPRSS2 HS3ST5 C3 PRRG3	4.68e-05	199	88	5	2b357cc08c425a58d45aa6c086101c8fff53e218
ToppCell	LPS_IL1RA-Epithelial_alveolar\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.68e-05	199	88	5	5b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC7A8 ABCA1 CLIC4 SLC15A3 CPVL	4.68e-05	199	88	5	c4fc638a8dad3a9b77634e8912a9326c8a2f11f5
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT ODC1	4.68e-05	199	88	5	0447f8f53389fe7c6ddc04a97d86e74122ea16f4
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.68e-05	199	88	5	7b21447bb39cdba37539a12cb475f463010fc23f
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	DOCK2 SLC7A8 C3 SLC15A3 CPVL	4.68e-05	199	88	5	4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9
ToppCell	ASK454-Immune-B_cell\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	ABCA3 C3 CAT ODC1 CPVL	4.68e-05	199	88	5	b9b0ae81b9e7e35023c73d3b936e88167461ba54
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 AKR7A3 TMPRSS2 C3 CAT	4.68e-05	199	88	5	ccdde5d4bcc72f230a1dd2544ee7f4dfb98a5e80
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC7A8 ABCA1 CLIC4 SLC15A3 CPVL	4.68e-05	199	88	5	697a9a58c0cdb77222700d029873355d37f6ab28
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	DOCK2 SLC7A8 C3 SLC15A3 CPVL	4.68e-05	199	88	5	3ba48a4715d5e9387650aa97e0c5d7f7897bf380
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABCA3 TMPRSS2 C3 CAT CADPS2	4.79e-05	200	88	5	c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE DOCK2 MYO7B SLC15A3 CPVL	4.79e-05	200	88	5	a443e475e7a10c26a6173d1af961de6219e0e567
ToppCell	control-HLA-DR-_S100A+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NAGA SNX27 CAT CPVL F5	4.79e-05	200	88	5	107a0665fb20247511a430178effd7630a619488
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA3 AKR7A3 TMPRSS2 C3 CADPS2	4.79e-05	200	88	5	9a6ae40f3e17cd44ee5fd73260713b920aa2ea15
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC12A2 ANO1 TMPRSS2 CADPS2 SLC44A3	4.79e-05	200	88	5	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE DOCK2 MYO7B SLC15A3 CPVL	4.79e-05	200	88	5	ed785a6d08ca2b350dc3307b587eadfb2886d1f9
Computational	Oxidoreductases.	AKR7A3 IDH2 AKR7A2	6.15e-05	15	57	3	MODULE_519
Drug	chlordecone	C3 CAT ODC1 IDH2 FOXG1	5.49e-06	67	86	5	CID000000299
Drug	Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	LIMK2 ABCA1 COL10A1 CARF SLC35E3 DNASE2 FOXG1	9.52e-06	196	86	7	2530_UP
Drug	6,9,12-octadecatrienoic acid	GLA TECR IDH2 AKR7A2 SULT1E1	1.16e-05	78	86	5	CID000003453
Drug	liu	GLA PIK3CB RRM2B NTN1 CAT QARS1 FOXG1 TOP2B	1.25e-05	285	86	8	CID015991562
Disease	Fabry disease (implicated_via_orthology)	GLA NAGA	7.82e-06	2	83	2	DOID:14499 (implicated_via_orthology)
Disease	X-24462 measurement	AKR7A3 AKR7A2	2.34e-05	3	83	2	EFO_0800886
Disease	Seizures	RRM2B NAGA SNX27 CAT IDH2 FOXG1	3.57e-05	218	83	6	C0036572
Disease	sciatic neuropathy (biomarker_via_orthology)	CAPN2 C3 CAT QARS1	1.79e-04	99	83	4	DOID:11446 (biomarker_via_orthology)
Disease	sensorineural hearing loss (biomarker_via_orthology)	SLC12A2 CAT	2.16e-04	8	83	2	DOID:10003 (biomarker_via_orthology)
Disease	aflatoxin B1 aldehyde reductase member 2 measurement	AKR7A3 AKR7A2	2.16e-04	8	83	2	EFO_0020132
Disease	cataract (is_marker_for)	CRYBA1 CAT	2.78e-04	9	83	2	DOID:83 (is_marker_for)
Disease	osteonecrosis (is_implicated_in)	CAT F5	3.47e-04	10	83	2	DOID:10159 (is_implicated_in)
Disease	3-hydroxypropylmercapturic acid measurement	TRHDE PIK3CB TMPRSS2 NTN1 CADPS2 AGBL1	4.82e-04	352	83	6	EFO_0007014
Disease	rostral middle frontal gyrus volume measurement	NTN1 AGBL1	6.96e-04	14	83	2	EFO_0010328
Disease	MMR-related febrile seizures	CAPN2 AGBL1	8.02e-04	15	83	2	EFO_0006519
Disease	ocular hypertension (biomarker_via_orthology)	CRYBA1 C3	1.03e-03	17	83	2	DOID:9282 (biomarker_via_orthology)
Disease	Renal Insufficiency	GLA IDH2	1.03e-03	17	83	2	C1565489
Disease	Colorectal Neoplasms	ABCA1 ABCA3 BUB1 LAMA1 ODC1	1.12e-03	277	83	5	C0009404
Disease	stem Cell Growth Factor beta measurement	PIEZO2 KDM4C F5	1.25e-03	75	83	3	EFO_0008292
Disease	oleoylcarnitine measurement	AKR7A3 AKR7A2	1.30e-03	19	83	2	EFO_0021043
Disease	Kidney Failure	GLA IDH2	1.74e-03	22	83	2	C0035078
Disease	lung adenocarcinoma (is_marker_for)	COL10A1 IDH2 PLOD2	1.80e-03	85	83	3	DOID:3910 (is_marker_for)
Disease	partial thromboplastin time	F5 AGBL1	2.07e-03	24	83	2	EFO_0004310
Disease	Degenerative polyarthritis	CLIC4 IDH2 PLOD2	2.32e-03	93	83	3	C0029408
Disease	Osteoarthrosis Deformans	CLIC4 IDH2 PLOD2	2.32e-03	93	83	3	C0086743
Disease	inflammatory biomarker measurement	PIEZO2 F5	2.43e-03	26	83	2	EFO_0004872
Disease	white matter integrity, age at assessment	CARF NTN1	2.43e-03	26	83	2	EFO_0004641, EFO_0008007

Protein segments in the cluster

Peptide	Gene	Start	Entry
YLYPGWNMEKQRFLT	TRHDE	476	Q9UKU6
MNLYTVYIIKGYWPL	CHRM4	86	P08173
AQGRWVKTMEVYPYL	ERVPABLB-1	296	P60509
KSNGWILPTVYQGMY	AKR7A2	186	O43488
PKEMTGIWRYLTNAY	CLIC4	211	Q9Y696
GWILPTVYQGMYNAI	AKR7A3	161	O95154
MLSNKPWNYQIDYFG	BUB1	976	O43683
TGKYPSWTFYIQVMT	CAT	271	P04040
VYNEGQQFMPWYKFD	APOBEC3B	161	Q9UH17
GVMTWYIEAVFPGQY	ABCA1	836	O95477
FGKYPSLELQPWMYN	ABCA1	1371	O95477
PELVNMGQWKIRAYY	C3	196	P01024
MGQWKIRAYYENSPQ	C3	201	P01024
VLYGLVTWYMEAVFP	ABCA3	461	Q99758
LYMWPFQKPNYTEIR	GLA	206	P06280
NSVFIDWDVQMYYKP	ATP8B3	456	O60423
LQFYWVTGFPIQMPY	CC2D2B	1371	Q6DHV5
QWFYFKVSGMQAAIP	AGBL1	631	Q96MI9
IYKSMDYGRTWVPFQ	NTN1	161	O95631
WVPFQFYSTQCRKMY	NTN1	171	O95631
MLTGVPVYFLGVYWQ	SLC7A8	456	Q9UHI5
LPISYEGQYIWNMLF	NLRP11	56	P59045
TFPLGWLYFQIGYMI	ELOVL5	226	Q9NYP7
KKRYTVVGNPYWMAP	LIMK2	501	P53671
MWKSQYVPYDGIPFV	CARF	261	Q8N187
MINRFIYGKGWDPYV	CPVL	461	Q9H3G5
IMKNFPYYRENKQGW	FOXG1	211	P55316
VTMNISQMITYWGYP	LIPF	31	P07098
IEWYRKKMPFSYPQQ	HS3ST5	136	Q8IZT8
GVIYLKNMITQYWPD	IPO7	56	O95373
QMLYNLWGPDKTISY	OR2W6P	86	Q8NHA6
EGVNTPYLYFGMWKT	KDM4C	171	Q9H3R0
VIEGVNTPYLYFGMW	KDM4D	171	Q6B0I6
YFAWLGVYTQMLIPA	ANO1	331	Q5XXA6
MLPKYGDYYVWNKVT	OSBPL6	716	Q9BZF3
WNVPYMANVYLIKGK	PLOD2	456	O00469
FLGSMKPWNYKYNPQ	GYG2	246	O15488
VIITSYNIWNMDPGY	ATP6AP2	321	O75787
SQIYEWMVSCVPYFK	FOXO3B	266	A0A2Z4LIS9
FQYAIQKKWPLYMST	IDH2	236	P48735
QFSKMGKQLTYTYPW	DNASE2	166	O00115
YYQVKQPRWMETVKV	DOCK2	481	Q92608
MKIQSGAWVCYQYPG	CRYBA1	161	P05813
TLLKMWFPEVQNIYY	DNAH7	326	Q8WXX0
WVQAMYRATGQSYKP	CADPS2	581	Q86UW7
LDGYQIPKGWSVMYS	CYP26C1	396	Q6V0L0
IWGSVMYPYQLQQEL	MS4A4E	86	Q96PG1
IPMKPYYTKVYQEIW	ATP5MJ	11	P56378
GQVEYKPLSGIRYMW	SLC44A3	366	Q8N4M1
NYPNTFWMNPQYLIK	CAPN2	376	P17655
VTLVPYWMVYFQMQS	SLC15A3	321	Q8IY34
YYVMSGPAWQLMQQF	ODC1	406	P11926
GMPTLAVDFIYNYWK	JADE3	421	Q92613
AAIYLKNMVTQYWPD	IPO8	56	O15397
MVAWLGYTPYKVTYA	QARS1	321	P47897
YIGSVEPLTQFMWVY	TOP2B	71	Q02880
MIRAVQPGETYTYKW	F5	471	P12259
ETGMIVWFKYQKYPF	PWWP3B	391	Q5H9M0
NTAVMQRLAPKYYWA	LAMA1	556	P25391
YPVAWVNTMVFDFKG	PIK3CB	436	P42338
SVPATYQIYYMIGWK	NDUFAF5	296	Q5TEU4
QIWPVYVMFQLTYCK	OR9A4	156	Q8NGU2
WVGLYKNGTPVMYTY	COL10A1	611	Q03692
PIQYPDIWKMYKQAQ	RRM2B	46	Q7LG56
GWKPEISQDTMYLQY	ZDHHC6	86	Q9H6R6
PGVYGNVMVFTDWIY	TMPRSS2	471	O15393
YLSGLMYWPFVQLTN	MPV17L	126	Q2QL34
FMQGQVPYGSWYKHV	SULT1E1	161	P49888
PVMNTWFYITYEKDP	SPIN3	156	Q5JUX0
PAFKYYNMWISLLGA	SLC12A2	706	P55011
YLYTYKMPGDIKNWV	EXT2	606	Q93063
GNLVVAMFIKYWIYV	PIEZO2	676	Q9H5I5
FDGIMYYLTPQWDKI	SLC6A9	341	P48067
KPRWVKIFTPYFNYM	SNX27	496	Q96L92
GYVAEQFGWTVYIVM	SPCS1	106	Q9Y6A9
MPLRNIFKNCTYYWG	TECR	156	Q9NZ01
MVVSIGWNPYYKNTK	RFK	61	Q969G6
VNIIFPMYVTGKWNY	VN1R4	141	Q7Z5H5
PMYVTGKWNYTNITV	VN1R4	146	Q7Z5H5
WYKQPSSGEMIFLIY	TRAV14DV4	56	A0A0A6YYC5
MASFYWRIKNEPYQV	TTC17	231	Q96AE7
SQNKMWYPYGIAQVS	nan	101	Q6ZUG5
YYTWPKNMVVYAGVE	PSME4	1276	Q14997
PQAKQWFSMYKPITY	TPGS2	216	Q68CL5
PQPMGVFQKEYWNTY	ZNF75D	166	P51815
VQYYWVDVMLNPGSA	TRIM22	296	Q8IYM9
YGQQIPMEEKRGWYF	TTC22	186	Q5TAA0
MYIWNGYAVIGKQPK	TTC39A	461	Q5SRH9
TMEFWKGYPNAVYSV	PRRG3	56	Q9BZD7
IYWIIGNTSPVTYNM	SLC35E3	241	Q7Z769
PAVYTQICKYMSWIN	KLK10	256	O43240
NPSGVVMWYLYPIKN	NAGA	391	P17050
YQVYFMRKLWLNISP	MYO7B	1886	Q6PIF6
KIVPKNPYYFWSVMS	NAA25	141	Q14CX7